MIC of PASDAS could serve as an additional tool to understand patients’ perspectives of PsAFebruary 23, 2022Psoriatic Arthritis
Doppler signals and bone erosions at enthesis indicate more severe PsAFebruary 23, 2022Psoriatic Arthritis
PsA: Time to clinically meaningful response shorter with tofacitinib vs. placeboFebruary 23, 2022Psoriatic Arthritis
Psoriasis with concomitant psoriatic arthritis tied to an increased risk for endometriosisFebruary 23, 2022Psoriatic Arthritis
PsA: Secukinumab provides early and clinically meaningful improvements in patient-reported outcomesFebruary 23, 2022Psoriatic Arthritis
Patients are interrupting DMARD use well into the COVID-19 pandemicFebruary 17, 2022Psoriatic Arthritis
Severe Acute Systemic Reaction After the First Injections of IxekizumabFebruary 2, 2022Psoriatic Arthritis
A dermatologist-led model for CVD prevention in psoriasis may be feasibleFebruary 1, 2022Psoriatic Arthritis
